Jacob Belson appointed as CEO of Modcon Systems Ltd (Israel)
October 30, 2012
(Akko, Israel) - Jacob Belson, COO of Modcon Systems Ltd, has been named corporate vice president and chief executive officer for Modcon Systems operation in Israel. Jacob Belson will assume his role effective November 1, 2012. Jacob Belson holds B.Sc. in industrial management engineering, MBA in business administration and M.A in business coaching. He has [...]
Tecan and TAP Biosystems to automate RAFT™ 3D cell culture using Freedom EVO® system
October 30, 2012
Tecan and TAP Biosystems, a leading supplier of innovative cell culture systems, have announced a co¬marketing agreement to further expand the automated 3D cell culture capabilities of the Freedom EVO® liquid handling platform. Automation of TAP’s collagen-based RAFT™ cell culture system will allow scientists to quickly and conveniently create 3D cell cultures in a 96-well, [...]
Bio-Rad Acquires Cell Sorting System From Propel Labs
October 30, 2012
HERCULES, CA -- Bio-Rad Laboratories, Inc. (NYSE: BIO) and (NYSE: BIO.B), a multinational manufacturer and distributor of life science research and clinical diagnostic products today announced that they have acquired a new cell sorting system from Propel Labs. Under the terms of agreement, Bio-Rad has acquired an automated, easy-to-use benchtop sorting flow cytometer. The instrument [...]
Aspera expands its EMEA Operations to Support Triple-Digit Growth
October 30, 2012
EMERYVILLE, Calif -- High-speed file transfer innovator expands EMEA team to drive European expansion. On the back of unprecedented triple-digit growth, Aspera, Inc. (https://www.asperasoft.com/), creator of patented fasp™ transport technology that moves the world’s digital assets at maximum speed, has announced a series of strategic appointments to support further EMEA expansion across a range of [...]
Luminex Corporation Reports Third Quarter 2012 Results
October 29, 2012
AUSTIN, Texas, -- Luminex Corporation (NASDAQ:LMNX) today announced financial results for the third quarter ended September 30, 2012. Financial and operating highlights include the following: • Completed the acquisition of GenturaDx, Inc., effective July 11, 2012. Integration activities are on-track • Consolidated third quarter revenue of $50.0 million, a 10 percent increase over the third [...]
Interim report for the period January – September 2012
October 29, 2012
Third quarter July - September 2012 • Group net sales in the third quarter 2012 increased by 1 percent to 107.1 MSEK (106.6). At comparable exchange rates the sales were at the same level as the corresponding quarter 2011. • Operating profit in the quarter amounted to 8.9 MSEK (10.9). • The result after tax [...]
BioLife Solutions Products Now Used in More than 50 Clinical Trial-Stage Cellular Therapies
October 29, 2012
BOTHELL, Wash., -- BioLife Solutions, Inc. (OTCBB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and contract aseptic media manufacturer, today announced the Company's novel biopreservation technology is being used in more than 50 clinical trial-stage cellular therapies, making it the leading [...]
Roche launches new Cedex Bio HT Analyzer for cell fermentation process analytics
October 29, 2012
New instrument completes portfolio for customers with high-throughput applications Today Roche announced the global launch of its Cedex Bio HT Analyzer for the highly reliable determination of metabolites and substrates in mammalian and microbial cell fermentation. The Cedex Bio HT System offers very precise analytics, a broad test portfolio allowing flexible adaption of additional test [...]
Neogen’s ANSR™ for Listeria AOAC now approved
October 29, 2012
LANSING, Mich., — Neogen Corporation (Nasdaq: NEOG) has received Performance Tested MethodSM Certi? cation from the AOAC Research Institute for its new ANSR™ for Listeria assay, which is designed for rapid and de? nitive detection of Listeria. The issuance of this certi? cate, Number 101202 from the AOAC Research Institute, independently con? rms the performance [...]
October 29, 2012
Rockland Immunochemicals Inc., a biotechnology company manufacturing antibodies and antibody-based tools for basic research, diagnostic assay development and preclinical studies is pleased to announce the expansion of a licensing and commercialization relationship with Lankenau Institute for Medical Research (LIMR) through its business development subsidiary LIMR Development, Inc. (LDI). Instrumental in advancing this relationship was Carl [...]

